Eli Lilly reports positive results for obesity drug retatrutide trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. LMT
6. SPY
7. RXST
8. SPGI
9. RIVN
10. BFH

Go back to Eli Lilly reports positive results for obesity drug retatrutide trials
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1239.49 +39.43 (3.29%)
Previous Close $1200.06    52 Week High $88.16 
Open $1232.88    52 Week Low $67.88 
Day High $1249.45    P/E 286.92 
Day Low $1222.77    EPS $4.32 
Volume 1,136,453